CFIUS drawing line in sand on personal data

The Trump administration has further reinforced which kinds of life science investments will be off limits for foreign investors, as reports emerge that CFIUS is compelling two more Chinese firms to relinquish control over companies that collect U.S. citizens’ personal data.

CNBC reported Thursday that the Committee on Foreign Investment in the United States is forcing iCarbonX Inc. (Shenzhen) to sell its stake in PatientsLikeMe Inc. (Cambridge, Mass.), which aggregates patient-generated health data via an online platform. The report cited undisclosed sources.

iCarbonX initially invested $100 million through its Digital

Read the full 883 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE